FNDC5 and Alzheimer disease: The RNA sequencing data obtained from the Mount Sinai School of Medicine and Mayo (MSSM) study, comprising a total of 2114 samples derived from 1234 individuals, showed a significant decrease in FNDC5 expression in the parahippocampal gyrus of individuals diagnosed with AD compared to the control group (17).